We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
10 hedge funds and large institutions have $18.1M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
4,190% more capital invested
Capital invested by funds: $422K → $18.1M (+$17.7M)
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
67% more funds holding
Funds holding: 6 → 10 (+4)
Holders
10
Holders Change
+4
Holders Change %
+66.67%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CV
Clarus Ventures
Cambridge,
Massachusetts
|
+$18.3M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$3.44M |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$12.6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$5.64K |
| 5 |
Morgan Stanley
New York
|
+$3.76K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$10K |